Sat 14 Nov 2026 11:15:53 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2026-02-05
  • RTF Template


    Regierungspraesidium Tuebingen Leitstelle Arzneimittelueberwachung Baden-Wuerttemberg

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

    Human medicinal products and Veterinary medicinal products


    1. Authorisation Number

    :

    DE_BW_01_WDA_2019_0001_Glatt Pharmaceutical

    2. Name of Authorisation Holder

    :

    Glatt Pharmaceutical Services GmbH & Co. KG

    (ORG-100011667 / LOC-100018538)

    3. Address(es) of Site(s)

    :

    Werner-Glatt-Str. 1, Binzen, 79589, Germany 

    Im Entenbad 4, Brombach, Loerrach, Baden-Wuerttemberg, 79541, Germany 




    4. Legally registered address of Authorisation Holder

    :

    Werner-Glatt-Str. 1, Binzen, 79589, Germany

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :

    Art. 77(1) of Directive 2001/83/EC
    Art. 99 of Regulation (EU) 2019/6

    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2019-10-29

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: Glatt Pharmaceutical Services GmbH & Co. KG

    (ORG-100011667 / LOC-100018538)

    , Werner-Glatt-Str. 1, Binzen, 79589, Germany   



    Human medicinal products

    Veterinary medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)

       1.2. without a Marketing Authorisation in the EEA and intended for EEA market

       1.3. without a Marketing Authorisation in the EEA and intended for exportation


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 

       2.4. Export 

       2.5. Other activities(s): order management, financial processing, reportings, balancing


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.1. Narcotic or psychotropic products 

       3.3. Cold chain products(requiring low temperature handling) 




    Name and address of the site: Glatt Pharmaceutical Services GmbH & Co. KG

    (ORG-100011667 / LOC-100031300)

    , Im Entenbad 4, Brombach, Loerrach, Baden-Wuerttemberg, 79541, Germany   



    Human medicinal products

    Veterinary medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)

       1.2. without a Marketing Authorisation in the EEA and intended for EEA market

       1.3. without a Marketing Authorisation in the EEA and intended for exportation


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 

       2.4. Export 

       2.5. Other activities(s): order management, financial processing, reportings, balancing


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.1. Narcotic or psychotropic products 

       3.3. Cold chain products(requiring low temperature handling) 










    Reason for Withdrawing:

    GHE has been updated to the current version GHE DE_BW_01_WDA_2026_001_Glatt Pharmaceutical.

    GHE wurde aktualisiert aktuelle GHE DE_BW_01_WDA_2026_001_Glatt Pharmaceutical








    Union Format for a Wholesale Distribution Authorisation

    DE_BW_01_WDA_2019_0001_Glatt Pharmaceutical


    Page 1





    Loading, please wait